Combinatorial drug therapy for cancer in the post-genomic era

Al-Lazikani, Bissan, Banerji, Udai, Workman, Paul·2012·Nature Biotechnology

DOI 10.1038/nbt.2284

Cited by (999)

Items 101–200 of 999

Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects
Heli Julkunen, Anna Cichońska, Prson Gautam, Sándor Szedmák, Jane Douat, Tapio Pahikkala, Tero A. Aittokallio, Juho Rousu · 2020 · Nature Communications
Methotrexate–Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy
Yang Li, Jinyan Lin, Jinyuan Ma, Liang Song, Huirong Lin, Bowen Tang, Dengyue Chen, Guanghao Su, Shefang Ye, Xuan Zhu et al. · 2017 · ACS Applied Materials & Interfaces
Carrier-free functionalized multidrug nanorods for synergistic cancer therapy
Mengjiao Zhou, Xiujuan Zhang, Yinlong Yang, Zhuang Liu, Baishun Tian, Jiansheng Jie, Xiaohong Zhang · 2013 · Biomaterials
Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
Takahiro Domoto, Masahiro Uehara, Dilireba Bolidong, Toshinari Minamoto · 2020 · Cells
Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles
Qin Liu, Rutian Li, Hanqing Qian, Jia Wei, Xie Li, Jie Shen, Mi Yang, Xiaoping Qian, Lixia Yu, Xiqun Jiang et al. · 2013 · Biomaterials
Inhibition of Multidrug Resistance of Cancer Cells by Co‐Delivery of DNA Nanostructures and Drugs Using Porous Silicon Nanoparticles@Giant Liposomes
Feng Kong, Xu Zhang, Hongbo Zhang, Xiangmeng Qu, Dong Chen, Mark Roy Servos, Ermei M. Mäkilä, Jarno Salonen, Hélder A. Santos, Mingtan Hai et al. · 2015 · Advanced Functional Materials
Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy
Ronnie H. Fang, Ashley V. Kroll, Liangfang Zhang · 2015 · Small
Integration of phytochemicals and phytotherapy into cancer precision medicine
Thomas Efferth, Mohamed E.M. Saeed, Elhaj Mirghani, Awadh Alim, Zahir Yassin, Elfatih M. Saeed, Hassan E. Khalid, Salah Daak · 2017 · Oncotarget
Senolytics and Senostatics: A Two-Pronged Approach to Target Cellular Senescence for Delaying Aging and Age-Related Diseases.
Chanhee Kang · 2019 · Europe PMC (PubMed Central)
pH-Responsive charge switchable PEGylated ε-poly-l-lysine polymeric nanoparticles-assisted combination therapy for improving breast cancer treatment
Zhihao Guo, Junhui Sui, Mengcheng Ma, Jianshe Hu, Yong Sun, Liqun Yang, Yujiang Fan, Xingdong Zhang · 2020 · Journal of Controlled Release
XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer
J J Morton, G Bird, Stephen B. Keysar, David P. Astling, Traci Renae Lyons, Roger T. Anderson, M. Glogowska, P Estes, Justin R. Eagles, Phuong N. Le et al. · 2015 · Oncogene
Advances with support vector machines for novel drug discovery
Vinícius Gonçalves Maltarollo, Thales Kronenberger, Gabriel Zarzana Espinoza, Patrícia Rufino Oliveira, Káthia M. Honório · 2018 · Expert Opinion on Drug Discovery
In-silico Prediction of Synergistic Anti-Cancer Drug Combinations Using Multi-omics Data
Celebi, Remzi, Bear Don’t Walk, Oliver, Movva, Rajiv, Alpsoy, Semih, Dumontier, Michel · 2019 · Scientific Reports
Dual Drug Conjugated Nanoparticle for Simultaneous Targeting of Mitochondria and Nucleus in Cancer Cells
Abhik Mallick, Piyush A. More, Sougata Ghosh, Rohan Chippalkatti, Balu Ananda Chopade, Mayurika Lahiri, Sudipta Basu · 2015 · ACS Applied Materials & Interfaces
DNA‐Au Nanomachine Equipped with i‐Motif and G‐Quadruplex for Triple Combinatorial Anti‐Tumor Therapy
Hyeongmok Park, Jinhwan Kim, Sung‐Jin Jung, Won Jong Kim · 2017 · Advanced Functional Materials
Recent advances in combinatorial drug screening and synergy scoring
Tea Pemovska, Johannes W. Bigenzahn, Giulio Superti‐Furga · 2018 · Current Opinion in Pharmacology
Catalyst discovery through megalibraries of nanomaterials
Edward J. Kluender, James L. Hedrick, Keith A. Brown, Rahul S. Rao, Brian Meckes, Jingshan S. Du, Liane M. Moreau, Benji Maruyama, Chad Alexander Mirkin · 2018 · Proceedings of the National Academy of Sciences
Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy
Mingyue Yang, Ruirui Zhao, Yifan Fang, Jiali Jiang, Xiaotian Yuan, Jingwei Shao · 2019 · International Journal of Pharmaceutics
Synthetically Lethal Interactions of ATM, ATR, and DNA-PKcs
Omar L. Kantidze, Artem K. Velichko, Artem V. Luzhin, Nadezhda V. Petrova, Sergey V. Razin · 2018 · Trends in cancer
Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer
Kacoli Sen, Shubhadeep Banerjee, Mahitosh Mandal · 2019 · Colloids and Surfaces B Biointerfaces
Genotype-Selective Combination Therapies for Melanoma Identified by High-Throughput Drug Screening
Matthew A. Held, Casey G. Langdon, James T. Platt, Tisheeka Graham-Steed, Zongzhi Z. Liu, Ashok K. Chakraborty, Antonella Bacchiocchi, Andrew Koo, Jonathan W. Haskins, Marcus Bosenberg et al. · 2012 · Cancer Discovery
ROS-triggered and regenerating anticancer nanosystem: An effective strategy to subdue tumor's multidrug resistance
Zhigui Su, Minglei Chen, Yanyu Xiao, Minjie Sun, Li Zong, Sajid Asghar, Mei Dong, Huipeng Li, Qineng Neng Ping, Can Zhang · 2014 · Journal of Controlled Release
Cell Cycle–Targeted Cancer Therapies
Charles J. Sherr, Jiří Bártek · 2016 · Annual Review of Cancer Biology
Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat
Lianbin Yao, Nurulhuda Binte Mustafa, Eng Chong Tan, Anders Poulsen, Prachi Singh, Minh‐Dao Duong‐Thi, Jeannie X. T. Lee, Pondy Murugappan Ramanujulu, Wee Joo Chng, Jeffrey J. Y. Yen et al. · 2017 · Journal of Medicinal Chemistry
Folate-Functionalized Magnetic-Mesoporous Silica Nanoparticles for Drug/Gene Codelivery To Potentiate the Antitumor Efficacy
Tingting Li, Xue Shen, Yue Geng, Zhongyuan Chen, Li Li, Shun Li, Hong Yang, Chunhui Wu, Hongjuan Zeng, Yiyao Liu · 2016 · ACS Applied Materials & Interfaces
Modern bioinformatics meets traditional Chinese medicine
P. Gu, Hongliang Chen · 2013 · Briefings in Bioinformatics
Multi-drug delivery system based on alginate/calcium carbonate hybrid nanoparticles for combination chemotherapy
Jinlong Wu, Chaoqun Wang, Ren‐Xi Zhuo, Si‐Xue Cheng · 2014 · Colloids and Surfaces B Biointerfaces
Computational Modeling of ERBB2 -Amplified Breast Cancer Identifies Combined ErbB2/3 Blockade as Superior to the Combination of MEK and AKT Inhibitors
Daniel C. Kirouac, Jin Y. Du, Johanna Lahdenranta, Ryan P. Overland, Defne Yarar, Violette B. Paragas, Emily A. Pace, Charlotte Fenton McDonagh, Ulrik B. Nielsen, Matthew David Onsum · 2013 · Science Signaling
INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases
Beekhof, Robin, van Alphen, Carolien, Henneman, Alex A, Knol, Jaco C, Pham, Thang V, Rolfs, Frank, Labots, Mariette, Henneberry, Evan, Le Large, Tessa YS, de Haas, Richard R et al. · 2019 · Molecular Systems Biology
Cytotoxic Effects of Plant Sap-Derived Extracellular Vesicles on Various Tumor Cell Types
Kimin Kim, Hye Ju Yoo, Jik‐Han Jung, Ruri Lee, Jaekyung Hyun, Ji‐Ho Park, Dokyun Na, Ju Hun Yeon · 2020 · Journal of Functional Biomaterials
Machine learning approaches for drug combination therapies
Betül Güvenç Paltun, Samuel Kaski A, Hiroshi Mamitsuka · 2021 · Briefings in Bioinformatics
An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells
Abedi, Fatemeh, Davaran, Soodabeh, Hekmati, Malak, Akbarzadeh, Abolfazl, Baradaran, Behzad, Moghaddam, Sevil Vaghefi · 2021 · Journal of Nanobiotechnology
Bio-responsive alginate-keratin composite nanogels with enhanced drug loading efficiency for cancer therapy
Zhe Sun, Yi Zeng, Huaiying Zhang, Xiaomin Ma, Wen Su, Xiaoyu Sun, Xudong Li · 2017 · Carbohydrate Polymers
Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers
Bowen Li, Liang Yang, Xueqiang Peng, Qin Fan, Shibo Wei, Shuo Yang, Xinyu Li, Hongyuan Jin, Bo Wu, Mingyao Huang et al. · 2020 · Biomedicine & Pharmacotherapy
Systems Pharmacology: Defining the Interactions of Drug Combinations
J. G. Coen van Hasselt, Ravi Iyengar · 2018 · The Annual Review of Pharmacology and Toxicology
Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis
Caitong Yu, Mengjiao Zhou, Xiujuan Zhang, Weijia Wei, Xianfeng Chen, Xiaohong Zhang · 2015 · Nanoscale
Privileged scaffolds in lead generation
Hongyu Zhao, Justin D. Dietrich · 2015 · Expert Opinion on Drug Discovery
Microfluidics as a cutting-edge technique for drug delivery applications
Flavia Fontana, Mónica P. A. Ferreira, Alexandra Correia, Jouni J. Hirvonen, Hélder A. Santos · 2016 · Journal of Drug Delivery Science and Technology
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade
Antonio Marchini, Eleanor M. Scott, Jean Rommelaere · 2016 · Viruses
Imaging drug uptake by bioorthogonal stimulated Raman scattering microscopy
William J. Tipping, Martin W. Lee, Alan Serrels, Valerie G. Brunton, Alison N. Hulme · 2017 · Chemical Science
Patient-specific Boolean models of signalling networks guide personalised treatments
Arnau Montagud, Jonas Béal, Luis Tobalina, Pauline Traynard, Vigneshwari Subramanian, Bence Szalai, Róbert Alföldi, László Géza Puskás, Alfonso Valencia, Emmanuel Barillot et al. · 2022 · eLife
Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems
Merel van Elk, Bruce P. Murphy, Tatiane Eufrásio-da-Silva, Daniel P. O’Reilly, Tina Vermonden, Wim E. Hennink, Garry P. Duffy, Eduardo Ruiz‐Hernández · 2016 · International Journal of Pharmaceutics
Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling
Mario Niepel, Marc A. Hafner, Qiaonan Duan, Zichen Wang, Evan Paull, Mirra Chung, Xiaodong Lü, Joshua M. Stuart, Todd R. Golub, Aravind Subramanian et al. · 2017 · Nature Communications
miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression
Wenjing Mu, Chaobo Hu, Haibin Zhang, Zengqiang Qu, Jin Cen, Zhixin Qiu, Chao Li, Haozhen Ren, Yixue Li, Xianghuo He et al. · 2015 · Cell Research
Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines
Eugene Guorong Yang, Nurulhuda Binte Mustafa, Eng Chong Tan, Anders Poulsen, Pondy Murugappan Ramanujulu, Wee Joo Chng, Jeffrey J. Y. Yen, Brian William Dymock · 2016 · Journal of Medicinal Chemistry
Polypharmacology in Precision Oncology: Current Applications and Future Prospects
Albert A. Antolín, Paul Workman, Jordi Mestres, Bissan Al‐Lazikani · 2016 · Current Pharmaceutical Design
Inorganic Nanomaterial‐Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities
Guanyou Lin, Richard A. Revia, Miqin Zhang · 2020 · Advanced Functional Materials
Approaches to modernize the combination drug development paradigm
Daphne Day, Lillian L. Siu · 2016 · Genome Medicine
Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways
Jing Ping Tang, Leena Karhinen, Tao Xu, Agnieszka Szwajda, Bhagwan Yadav, Krister Wennerberg, Tero A. Aittokallio · 2013 · PLoS Computational Biology
Combining Allosteric and Orthosteric Drugs to Overcome Drug Resistance
Duan Ni, Yun Li, Yuran Qiu, Jun Pu, Shaoyong Lu, Jian Zhang · 2020 · Trends in Pharmacological Sciences
Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets
Miller, Martin L., Molinelli, Evan J., Nair, Jayasree S., Sheikh, Tahir, Samy, Rita, Jing, Xiaohong, He, Qin, Korkut, Anil, Crago, Aimee M., Singer, Samuel et al. · 2013 · Science Signaling
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution
Anderson, Grace R., Winter, Peter S., Lin, Kevin H., Nussbaum, Daniel P., Cakir, Merve, Stein, Elizabeth M., Soderquist, Ryan S., Crawford, Lorin, Leeds, Jim C., Newcomb, Rachel et al. · 2017 · Cell Reports
Poly (vinyl alcohol)/chitosan layer-by-layer microneedles for cancer chemo-photothermal therapy
André Ferreira Moreira, Carolina F. Rodrigues, Telma A. Jacinto, Sónia P. Miguel, Elisabete C. Costa, Ilídio Joaquim Correia · 2019 · International Journal of Pharmaceutics
Leukaemia 'firsts' in cancer research and treatment
Melvyn F. Greaves · 2016 · Nature reviews. Cancer
Tumor microenvironment-activated self-recognizing nanodrug through directly tailored assembly of small-molecules for targeted synergistic chemotherapy
Yang Li, Jinyan Lin, Zhixiong Cai, Peiyuan Wang, Qiang Luo, Cuiping Yao, Yun Zhang, Zhenqing Hou, Jingfeng Liu, Xiaolong Liu · 2020 · Journal of Controlled Release
Opportunities and challenges in combination gene cancer therapy
Nastiuk, Kent L., Krolewski, John J. · 2016 · Advanced Drug Delivery Reviews
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
Aaron C. Tan, Stephen Joseph Bagley, Patrick Yung Wen, Michael K. Lim, Michael Platten, Howard Colman, David M. Ashley, Wolfgang Wick, Susan Marina Chang, Evanthia Galanis et al. · 2021 · Journal for ImmunoTherapy of Cancer
Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin
Mengjie Rui, Yuanrong Xin, Ran Li, Yanru Ge, Chunlai Feng, Ximing Xu · 2016 · Molecular Pharmaceutics
On-chip anticancer drug screening – Recent progress in microfluidic platforms to address challenges in chemotherapy
Nandini Dhiman, Peter Kingshott, Hüseyin Sümer, Chandra Shekhar Sharma, Subha Narayan Rath · 2019 · Biosensors and Bioelectronics
Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles
Kin Man Au, Yuanzeng Min, Xi Tian, Longzhen Zhang, Virginia Perello, Joseph Michael Caster, Andrew Zhuang Wang · 2015 · ACS Nano
Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
Yeon-Jin Kwon, Kevin R. Petrie, Boris A. Leibovitch, Lei Zeng, Mihaly Mezei, Louise Howell, Veronica Gil, Rossitza Christova, Nidhi Bansal, Shuai Yang et al. · 2015 · Molecular Cancer Therapeutics
Cyclodextrin-based delivery systems for in vivo-tested anticancer therapies
Ana Cláudia Paiva‐Santos, Diana Costa, Laura Ferreira, Catarina Guerra, Miguel Pereira‐Silva, Irina Pereira, Diana Peixoto, Nuno R. Ferreira, Francisco Veiga · 2020 · Drug Delivery and Translational Research
Engineered gold nanoparticles for photothermal cancer therapy and bacteria killing
Alireza Gharatape, Soodabeh Davaran, Roya Salehi, Hamed Hamishehkar · 2016 · RSC Advances
Current and Future Approaches for Effective Cancer Imaging and Treatment
Merve Karpuz, Mine Silindir‐Gunay, A. Yekta Özer · 2018 · Cancer Biotherapy and Radiopharmaceuticals
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase
Jingkun Zeng, Florian Weissmann, Agustina P. Bertolin, Viktor Posse, Berta Canal, Rachel Ulferts, Mary Wu, Ruth Harvey, Saira Hussain, Jennifer C. Milligan et al. · 2021 · Biochemical Journal
In silico drug combination discovery for personalized cancer therapy
Minji Jeon, Sunkyu Kim, Sung‐Joon Park, Heewon Lee, Jaewoo Kang · 2018 · BMC Systems Biology
Light‐Triggered Efficient Sequential Drug Delivery of Biomimetic Nanosystem for Multimodal Chemo‐, Antiangiogenic, and Anti‐MDSC Therapy in Melanoma
Xing Ping Lai, Xue‐Liang Liu, Hong Pan, Mao‐Hua Zhu, Mei Long, Yihang Yuan, Zhong Zhang, Xiao Dong, Qin Lu, Peng Sun et al. · 2022 · Advanced Materials
Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450
Lorena Sánchez-Sánchez, Ruben Dario Cadena-Nava, Laura A. Palomares, Jaime Ruiz-Garcia, Melissa S. T. Koay, Jeroen J. L. M. Cornelissen, Rafael Vázquez-Duhalt · 2014 · Enzyme and Microbial Technology
Quantification of Pathway Cross-talk Reveals Novel Synergistic Drug Combinations for Breast Cancer
Samira Jaeger, Ana Igea, Rodrigo Arroyo, Víctor Alcalde, Begoña Cánovas, Modesto Orozco, Ángel R. Nebreda, Patrick Aloy · 2016 · Cancer Research
Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies
Disha D. Shah, Mehul R. Chorawala, Neha R. Raghani, Roopal Patel, Mohammad Fareed, Vivekanand Ankush Kashid, Bhupendra Gopalbhai Prajapati · 2025 · Medical Oncology
Nanoparticle-Mediated Mitochondrial Damage Induces Apoptosis in Cancer
Abhik Mallick, Piyush A. More, Muhammed Muazzam Kamil Syed, Sudipta Basu · 2016 · ACS Applied Materials & Interfaces
Heterodinuclear Pt( iv )–Ru( ii ) anticancer prodrugs to combat both drug resistance and tumor metastasis
Lili Ma, Rong Ma, Zhigang Wang, Shek‐Man Yiu, Guangyu Zhu · 2016 · Chemical Communications
Executable cancer models: successes and challenges
Matthew A. Clarke, Jasmin Fisher · 2020 · Nature reviews. Cancer
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety
Cynthia L. Palmer, Britton W. Boras, Bernadette Pascual, Na Li, Danan Li, Scott J. Garza, Nanni H. Huser, Jing Tang Yuan, Julie A. Cianfrogna, Tae Sung et al. · 2025 · Cancer Cell
Critical parameters in targeted drug development: the pharmacological audit trail
Udai Banerji, Paul Workman · 2016 · Seminars in Oncology
Recent advances in phytochemical based nano-drug delivery systems to combat breast cancer: A review
Raghu Solanki, Bhavana Jodha, Kleopatra Eligy Prabina, Niharika Aggarwal, Sunita Patel · 2022 · Journal of Drug Delivery Science and Technology
Patient-Customized Drug Combination Prediction and Testing for T-cell Prolymphocytic Leukemia Patients
Liye He, Jing Ping Tang, Emma Irene Andersson, Sanna Timonen, Steffen Koschmieder, Krister Wennerberg, Satu M. Mustjoki, Tero A. Aittokallio · 2018 · Cancer Research
Advances in combination therapy of lung cancer: Rationales, delivery technologies and dosage regimens
Lan Wu, Donglei Leng, Dongmei Cun, Camilla Foged, Mingshi Yang · 2017 · Journal of Controlled Release
Recent Advances in Hydrogel-Based Drug Delivery for Melanoma Cancer Therapy: A Mini Review
Sowmya Vishnubhakthula, Ravinder Elupula, Esteban F. Durán‐Lara · 2017 · Journal of Drug Delivery
When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease
S. D'Mello · 2021 · International Journal of Molecular Sciences
Evolving Therapeutic Strategies to Exploit Chromosome Instability in Cancer
Laura Thompson, Lucile M. Jeusset, Chloe C. Lepage, Kirk James McManus · 2017 · Cancers
Adaptive designs for dual-agent phase I dose-escalation studies
Jennifer Harrington, Graham Wheeler, Michael J. Sweeting, Adrian Mander, Duncan Ian Jodrell · 2013 · Nature Reviews Clinical Oncology
A chemical–genetic interaction map of small molecules using high‐throughput imaging in cancer cells
Marco Breinig, Felix A. Klein, Wolfgang K. Huber, Michael Boutros · 2015 · Molecular Systems Biology
Identification of candidate anti-cancer molecular mechanisms of Compound Kushen Injection using functional genomics
Zhipeng Qu, Jian Cui, Yuka Harata‐Lee, Thazin Nwe Aung, Qianjin Feng, Joy M Raison, Robert Daniel Kortschak, David L. Adelson · 2016 · Oncotarget
Earth-abundant photoelectrodes for water splitting and alternate oxidation reactions: Recent advances and future perspectives
Mahesh P. Suryawanshi, Uma V. Ghorpade, Cui Ying Toe, Umesh P. Suryawanshi, Mingrui He, Doudou Zhang, Jun Sung Jang, Seung Wook Shin, Jin Hyeok Kim, Xiaojing Hao et al. · 2023 · Progress in Materials Science
Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts
Xiaodong Ma, Xiaoqing Lv, Jiankang Zhang · 2017 · European Journal of Medicinal Chemistry
Driver network as a biomarker: systematic integration and network modeling of multi-omics data to derive driver signaling pathways for drug combination prediction
Lei Frank Huang, David J. Brunell, CLIFFORD C. STEPHAN, James J. Mancuso, Xiaohui Yu, Bin He, Timothy C. Thompson, Ralph Zinner, Jeri Kim, Peter J. Davies et al. · 2019 · Bioinformatics
Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells
Partha Laskar, Sukrut Somani, Sara J. Campbell, Margaret Mullin, Patricia Keating, Rothwelle J. Tate, Craig Irving, Hing Y. Leung, Christine Dufès · 2019 · Nanoscale
Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer
Ana I. Matos, Bárbara Carreira, Carina Peres, Liane I.F. Moura, João Conniot, Thibaut Fourniols, Anna Scomparin, Águeda Martínez‐Barriocanal, Diego Arango, João Pedro Conde et al. · 2019 · Journal of Controlled Release
Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp5 main protease
Jennifer C. Milligan, Theresa U. Zeisner, George Papageorgiou, Dhira Joshi, Christelle Soudy, Rachel Ulferts, Mary Wu, Chew Theng Lim, Kang Wei Tan, Florian Weissmann et al. · 2021 · Biochemical Journal
Advantages of Nanomedicine in Cancer Therapy: A Review
Chao Wang, Shan Zhang · 2023 · ACS Applied Nano Materials
Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
Alireza Azimi, Stefano Caramuta, Brinton A. Seashore-Ludlow, Johan Boström, Jonathan L. Robinson, Fredrik Edfors, Rainer Tuominen, Kristel Kemper, Oscar Krijgsman, Daniel S. Peeper et al. · 2018 · Molecular Systems Biology
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer
Yuhao Ren, Shanshan Li, Ren Zhu, Chengying Wan, Dongmei Song, Jiawen Zhu, Guiping Cai, Sihui Long, Lingyi Kong, Wenying Yu · 2021 · Journal of Medicinal Chemistry
Chlorotoxin—A Multimodal Imaging Platform for Targeting Glioma Tumors
Gadi Cohen, Scott Robert Burks, Joseph Alan Frank · 2018 · Toxins
Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim
Hye‐Kyung Park, J.L. Lee, Jaehwa Lim, Da‐Eun Jo, Soo‐Ah Park, Pann‐Ghill Suh, Byoung Heon Kang · 2014 · BMC Cancer
Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance
Yinghuan Li, Xi Tan, Xuhan Liu, Lingyan Liu, Yan Fang, Rong Rao, Yuanyuan Ren, Xiangliang Yang, Wei Liu · 2019 · Asian Journal of Pharmaceutical Sciences
Self-Targeted, Shape-Assisted, and Controlled-Release Self-Delivery Nanodrug for Synergistic Targeting/Anticancer Effect of Cytoplasm and Nucleus of Cancer Cells
Yang Li, Jinyan Lin, Yu Huang, Yanxiu Li, Xiangrui Yang, Hongjie Wu, Shichao Wu, Liya Xie, Lizong Dai, Zhenqing Hou · 2015 · ACS Applied Materials & Interfaces
Five-Feature Model for Developing the Classifier for Synergistic vs. Antagonistic Drug Combinations Built by XGBoost
Xiangjun Ji, Weida Tong, Zhichao Liu, Tieliu Shi · 2019 · Frontiers in Genetics
A review of machine learning approaches for drug synergy prediction in cancer
Anna Torkamannia, Yadollah Omidi, Reza Ferdousi · 2022 · Briefings in Bioinformatics
Synergy evaluation by a pathway–pathway interaction network: a new way to predict drug combination
Di Chen, Huamin Zhang, Peng Lu, Xianli Liu, Hongxin Cao · 2015 · Molecular BioSystems